Skip to main content

Table 1 The characteristics of patients between IMRT-SIB and CCRT

From: Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma

Items

IMRT-SIB

CCRT group

p

 

n = 129

n = 142

 
 

No of patients (%)

No of patients (%)

 

Gender

  

0.63

 Male

92 (71.3)

105 (73.9)

 Female

37 (28.7)

37 (26.1)

Age (year)

  

0.45

 ≤46

65 (50.4)

65 (45.8)

 >46

64 (49.6)

77 (54.2)

Pathology

  

0.02

Non-keratinization

  

 Differentiated

16 (9.3)

33 (23.2)

 Undifferentiatied

113 (90.7)

109 (76.7)

T stage

  

0.45

 T1

15 (11.6)

15 (10.6)

 T2

27 (20.9)

29 (20.4)

 T3

60 (46.5)

56 (39.4)

 T4

27 (20.9)

42 (29.6)

Stage

  

0.18

 III

89 (69.0)

87 (61.3)

 IV

40 (31.0)

55 (38.7)

Median dose to GTV

74

74

0.12

  1. IMRT-SIB: Intensity-modulated Radiotherapy with Simultaneous Integrated Boost, CCRT: Concurrent chemoradiotherapy, GTV: Gross tumor volume.